KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $983000.0.

  • National Health Investors' Share-based Compensation rose 4671.64% to $983000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 2067.63%. This contributed to the annual value of $4.2 million for FY2024, which is 918.57% down from last year.
  • As of Q3 2025, National Health Investors' Share-based Compensation stood at $983000.0, which was up 4671.64% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, National Health Investors' Share-based Compensation ranged from a high of $5.4 million in Q1 2021 and a low of $670000.0 during Q3 2024
  • For the 5-year period, National Health Investors' Share-based Compensation averaged around $1.6 million, with its median value being $992000.0 (2021).
  • Per our database at Business Quant, National Health Investors' Share-based Compensation surged by 24186.85% in 2021 and then crashed by 5858.74% in 2023.
  • Quarter analysis of 5 years shows National Health Investors' Share-based Compensation stood at $988000.0 in 2021, then grew by 4.96% to $1.0 million in 2022, then decreased by 16.59% to $865000.0 in 2023, then dropped by 22.54% to $670000.0 in 2024, then surged by 46.72% to $983000.0 in 2025.
  • Its Share-based Compensation was $983000.0 in Q3 2025, compared to $1.1 million in Q2 2025 and $2.6 million in Q1 2025.